Latest Tender Detail from department of health and family welfare DOHAFW for the corrigendum tender for inj. trastuzumab 440 mg , inj. phesgo trastuzumab plus pertuzumab 600 plus 600 mg by10ml , inj. palonosteron 0.25mg , inj. 5 flurouracal 500 mg , inj. cyclophosphamide 500mg , inj. pegfilgastrim 6 mg 0.6ml , genotype mtbdrsl ver 2.0 line probe assay for second line drug drug resistance testing under ntep , genotype mycobacterium as ver 2.0 detection of m tuberculosis complex and more than 20 clinically relevant ntm from cultures, purchase of drugs, inj. trastuzumab 440 mg, inj. phesgo (trastuzumab + pertuzumab) 600+600 mg/10ml, inj. palonosteron 0.25mg, inj. 5 flurouracal 500 mg, inj. cyclophosphamide 500mg, inj. pegfilgastrim 6 mg (0.6ml), genotype mtbdrsl ver 2.0 line probe assay for second line drug (drug resistance testing under ntep), genotype mycobacterium as ver 2.0 detection of m tuberculosis complex and more than 20 clinically relevant ntm from cultures in pondicherry, puducherry,. Reference number 15826351. Don't miss out on this chance to be part of a significant project. Register for free today to access the complete tender details and download the necessary documents. Seize the opportunity with Tender 18!
Looking For Complete Tender Bidding Consultancy? Our Technical Experts Will Help You Prepare And Submit Your Tender Successfully.